- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: PF-06438179/GP1111: An Infliximab Biosimilar ; volume:32 ; number:6 ; day:15 ; month:11 ; year:2018 ; pages:643 ; date:12.2018
BioDrugs ; 32, Heft 6 (15.11.2018), 643, 12.2018
- Urheber
-
Al-Salama, Zaina T.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-018-0316-z
- URN
-
urn:nbn:de:101:1-2019012519492864517647
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Al-Salama, Zaina T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
PF-06438179/GP1111: An Infliximab Biosimilar
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar
Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab)
Correction to: AVT04: An Ustekinumab Biosimilar
Correction to: SB8: A Bevacizumab Biosimilar
Correction to: AVT04: An Ustekinumab Biosimilar
Correction to: GP2015: An Etanercept Biosimilar
Correction to: PB006: A Natalizumab Biosimilar
Correction to: AVT02: An Adalimumab Biosimilar
A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion
PF-06438179/GP1111: An Infliximab Biosimilar
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar
Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab)
Correction to: AVT04: An Ustekinumab Biosimilar
Correction to: SB8: A Bevacizumab Biosimilar
Correction to: AVT04: An Ustekinumab Biosimilar
Correction to: GP2015: An Etanercept Biosimilar
Correction to: PB006: A Natalizumab Biosimilar
Correction to: AVT02: An Adalimumab Biosimilar
A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion
PF-06438179/GP1111: An Infliximab Biosimilar
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar
Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab)
Correction to: AVT04: An Ustekinumab Biosimilar
Correction to: SB8: A Bevacizumab Biosimilar
Correction to: AVT04: An Ustekinumab Biosimilar
Correction to: GP2015: An Etanercept Biosimilar
Correction to: PB006: A Natalizumab Biosimilar
Correction to: AVT02: An Adalimumab Biosimilar
A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product